Lv2
120 积分 2025-11-20 加入
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
1个月前
已完结
ARID1A-driven modulation of EZH2 impedes proliferation and enhances senescence in breast cancer cells
1个月前
已完结
Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies
1个月前
已完结
Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer
1个月前
已完结
Evidence from multicenter clinical studies and humanized mouse models indicates that glomerular mesangial IgA2 deposition contributes to the pathogenesis of IgA nephropathy
1个月前
已完结
Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer
1个月前
已完结
The AKT inhibitor AZD5363 elicits synthetic lethality in ARID1A-deficient gastric cancer cells via induction of pyroptosis
2个月前
已完结
Comprehensive molecular phenotyping ofARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities
3个月前
已完结
Mapping the genomic diaspora of gastric cancer
3个月前
已完结
Effects of different natural products in patients with non‐alcoholic fatty liver disease—A network meta‐analysis of randomized controlled trials
5个月前
已完结
皖公网安备34019202002308
